Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with Pulmonary Arterial Hypertension (EPITOME4)

INTRODUCTION: Pulmonary arterial hypertension (PAH) is associated with poor prognosis despite significant recent advances in its treatment. An intravenous formulation of epoprostenol sodium containing glycine and mannitol (epoprostenol GM; GlaxoSmithKline, London, UK) is widely used to treat PAH. A...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Tamura, Yuichi, Ono, Tomohiko, Fukuda, Keiichi, Satoh, Toru, Sasayama, Shigetake
格式: Artigo
語言:Inglês
出版: Springer Healthcare 2013
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3680653/
https://ncbi.nlm.nih.gov/pubmed/23653230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-013-0029-0
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍